A new COVID-19 medication has been approved in Abu Dhabi for the treatment of mild to moderate cases and those who have had direct contact with a patient.
The emirate's Department of Health (DoH) has partnered with Swiss healthcare company Roche to provide casirivimab and imdevimab to certain categories of patients.
The antibody combination has already been approved in the European Union and Japan, and conditionally approved in the UK and Australia.
It is also authorised for emergency use in the United States, India, Switzerland and Canada, and is recommended by the World Health Organisation (WHO).
.@DoHSocial has partnered with Swiss healthcare company @Roche to provide a new Covid-19 medication, approved for emergency use, to treat mild to moderate Covid-19 cases and those who have had direct contact with a positive case.
— مكتب أبوظبي الإعلامي (@ADMediaOffice) December 1, 2021
Read more: https://t.co/vGQXyUvhGB pic.twitter.com/Yj9JxVgemP
UAE President, European Council chief stress need to maintain Gaza ceasefire
H.H. Sheikh Ahmed hails national media as crucial pillar of development
Sheikha Bodour Al Qasimi appointed UNESCO Goodwill Ambassador
UAE unveils first Green Innovation District at Expo City
New partnership strengthens Dubai’s waste management strategy
2 men arrested in Fujairah within 3 hours of robbing bank customer
Man honoured for saving two girls from drowning in Sharjah's Mamzar
H.H. Sheikh Hamdan highlights Dubai’s vision for sustainable urban development
